Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular CarcinomaQiangbo Zhang, Zhao–You Tang|PLoS ONE|2013Cited by 60
TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathwaysQiangbo Zhang, Enyu Liu|Scientific Reports|2024Cited by 2
TLR3 activation enhances sorafenib-antitumor effect in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathwaysQiangbo Zhang, Enyu Liu|Research Square|2024Cited by 0